Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 1/2 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 13Gastrointestinal 9Other hematologic neoplasm 7Genitourinary 7Thoracic 6Plasma cell 6Other 6Gynecologic 6Sarcoma 4Myeloid 4Lymphoid 4Head & Neck 4Tumor-Agnostic 3CNS 3Classical hematology 2Other solid neoplasm 1Other neoplasm 1NET 1Endocrine 1Dermatologic 1

Conditions

Head and Neck Neoplasms 3cyclopia sequence 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Neoplasms, Unknown Primary 1Melanoma 1Gastrointestinal Neoplasms 1Fatigue 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Cisplatin 136Cetuximab 100pembrolizumab 82Radiotherapy 62Carboplatin 57Radiotherapy, Intensity-Modulated 54Fluorouracil 47Docetaxel 47Nivolumab 44Paclitaxel 37Radiation 21Erlotinib Hydrochloride 19durvalumab 17Platinum 15Ipilimumab 14Gemcitabine 13lenvatinib 12Drug Therapy 12Bevacizumab 12Albumin-Bound Paclitaxel 12vandetanib 111,2-diaminocyclohexaneplatinum II citrate 11Radiosurgery 10Pemetrexed 10Magnetic Resonance Spectroscopy 10Everolimus 10tremelimumab 9epacadostat 9Surgical Procedures, Operative 9Sorafenib 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Has results × Surveys and Questionnaires × Head & Neck × Clear all
NCT01624220 2026-05-12

A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy

M.D. Anderson Cancer Center

Phase NA Completed
41 enrolled 8 charts
BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Melanoma, Neoplasms, Unknown Primary, Prostatic Neoplasms, Sarcoma, Spinal Cord Neoplasms, Thyroid Neoplasms

NCT01927744 2025-11-26

Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection

M.D. Anderson Cancer Center

Phase 2 Completed
55 enrolled 8 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT01330446 2024-02-14

Single Agent Armodafinil for Patient-Reported Fatigue Following Radiation Therapy for Head and Neck Cancer

M.D. Anderson Cancer Center

Phase 1/2 Completed
26 enrolled 7 charts
Head & Neck

Fatigue, Head and Neck Neoplasms

NCT02055963 2022-10-20

Minocycline for Postsurgical Symptom Reduction in Head and Neck Cancer

M.D. Anderson Cancer Center

Phase 2 Terminated
30 enrolled 9 charts
Head & Neck

cyclopia sequence, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡